Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Omega ; 9(3): 3349-3362, 2024 Jan 23.
Article in English | MEDLINE | ID: mdl-38284096

ABSTRACT

Aims: Design and synthesis of antimicrobial prototypes that are capable of eradicating bacterial biofilm formation that is responsible for many health challenges particularly with antibiotic-resistant bacterial species. Materials and Methods: The utility of 1,3-diarylenones, aka chalcones, 3a-i and 8a-j as building blocks to construct the corresponding bis-pyrazoline derivatives 5aa-bh and 9ad-bj. Screening the antibacterial behavior of the novel bis-pyrazoline derivatives against methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant S. aureus (MRSA), and vancomycin-resistant S. aureus (VRSA) bacterial strains was investigated. Results: Chalcones were used as building scaffolds to construct two series of di- and trisubstituted bis-pyrazoline derivatives. Numerous novel bis-compounds displayed decent bacterial biofilm suppression. Conclusions: Two regioisomeric series of bis-chalcones were designed and constructed, and their structural diversity was manipulated to access the intrinsically bioactive, pyrazoline ring. The newly synthesized bis-pyrazoline derivatives presented decent antibacterial behavior against multiple drug-resistant bacterial strands (MSSA, MRSA, and VRSA).

2.
Future Med Chem ; 16(1): 27-41, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38063202

ABSTRACT

Aims: Development of some potent bis-thiazole and bis-thiazine derivatives that could be used as antiviral prototypes. Materials & methods: Xylenyl-spaced bis-carbazone scaffold 3 was used as a versatile building block for bis-thiazole derivatives 6a-e and 9a-d and bis-thiazine derivatives 12a-f. These bis-heterocycles were screened as herpes simplex virus type 1 (HSV-1) inhibitors. Results: The new bis-heterocyclic compounds showed remarkable antiviral activity (e.g., compound 6d cytotoxicity concentration CC50 >500 µg/ml). The antiviral capacity of the synthesized bis-compounds was supported by a molecular docking study against the glycoprotein D receptor of HSV-1. Compounds 6b, 9b, and 12c displayed the best binding coefficients. Conclusion: A new series of xylenyl-spaced bis-carbazone scaffolds were used as a building scaffold to construct a host of bis-thiazole/thiazine derivatives that could be used as antiviral prototypes.


Three series of potent antiviral prototypes were successfully designed. The building blocks of these prototypes are readily accessible from commercially available starting materials. These prototypes were tagged with thiazole moieties due to their diverse biological activities. These analogues were screened as herpes simplex virus type 1 (HSV-1) inhibitors to examine their antiviral potential. In vitro screening revealed that several prototypes possess good antiviral activities against an HSV-1 receptor compared with acyclovir. Compound 6d showed remarkable antiviral activity with a cytotoxicity concentration CC50 >500 µg/ml. The antiviral capability of the newly synthesized materials was supported by computational calculations against the surface glycoprotein D receptor of the HSV-1. Compounds 6b, 9b and 12c had the best binding affinity toward the target protein receptor, with binding energies of -9.5, -9.8 and -9.6 kcal/mol, respectively. These results were in great accord with the recorded in vitro screening data.


Subject(s)
Herpes Simplex , Herpesvirus 1, Human , Thiazines , Humans , Antiviral Agents/chemistry , Molecular Docking Simulation , Thiazoles/pharmacology , Thiazoles/therapeutic use , Thiazines/therapeutic use , Herpes Simplex/drug therapy
3.
Future Med Chem ; 14(24): 1881-1897, 2022 12.
Article in English | MEDLINE | ID: mdl-36420816

ABSTRACT

Aims: Development of antimicrobial agents having the ability to prevent bacterial biofilm formation which causes serious health problems, especially with antibiotic-resistant bacterial strains. Materials and methods: The use of 1,3-diaryl enones as structural motifs to access the pyridine core. Antimicrobial activities of the synthesized compounds against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and vancomycin-resistant S. aureus bacterial strains were investigated. Results: The newly synthesized bis-enones were used as building blocks to access some novel highly substituted bis-pyridine derivatives. Several novel bis-compounds showed great bacterial biofilm eradication activity. Conclusion: A new series of bis-chalcones was synthesized and their structural diversity was exploited to access the corresponding, more biologically active, pyridine core. These bis-pyridines showed respectable antibacterial activities against various drug-resistant bacterial strains: namely, methicillin-susceptible, methicillin-resistant and vancomycin-resistant S. aureus.


Subject(s)
Methicillin-Resistant Staphylococcus aureus , Molecular Docking Simulation , Methicillin , Microbial Sensitivity Tests , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry
4.
Drug Des Devel Ther ; 16: 2817-2832, 2022.
Article in English | MEDLINE | ID: mdl-36046334

ABSTRACT

Introduction: Antibiotic resistance is a global threat that has been increasing recently, especially with antibiotic overuse and misuse. The search for new antibiotics is becoming more and more indispensable. Methods: Design and synthesis of isatin derivatives as surrogates of SB-239629, a bacterial tyrosine-tRNA synthetases (TyrRS) inhibitor. The newly synthesized compounds were screened for their antimicrobial and antibiofilm activities. Docking studies were used to investigate potential binding modes of these compounds with TyrRS. Results and Discussion: Newly synthesized isatin-decorated thiazole derivatives (7b, 7d, and 14b) have shown potent antimicrobial activities against E. coli, a representative of gram-negative bacteria. Also, 7f showed the best activity against Methicillin Resistant Staphylococcus aureus (MRSA). In addition, 7h and 11f were found to have antifungal activities against Candida albicans equivalent to that of the reference Nystatin. All the new isatin derivatives with antimicrobial activities were found to exhibit strong biofilm distortion effects at half their minimum inhibitory concentrations (MIC). Moreover, thiazole derivatives 11a-f showed promising biofilm formation inhibition. Finally, molecular docking studies were used to investigate possible binding modes of target compounds with S. aureus and E. coli TyrRS. Conclusion: The novel isatin-decorated thiazole derivatives show strong antimicrobial and antifungal activities with potential action on TyrRS.


Subject(s)
Anti-Infective Agents , Isatin , Methicillin-Resistant Staphylococcus aureus , Anti-Bacterial Agents/chemistry , Anti-Infective Agents/pharmacology , Antifungal Agents/pharmacology , Biofilms , Escherichia coli/metabolism , Isatin/chemistry , Isatin/pharmacology , Microbial Sensitivity Tests , Molecular Docking Simulation , Staphylococcus aureus , Thiazoles/chemistry
5.
Med Chem ; 17(8): 875-886, 2021.
Article in English | MEDLINE | ID: mdl-33292124

ABSTRACT

BACKGROUND: There is a great need to discover more drugs with antimycobacterial activities to fight lung cancer and tuberculosis (two of the deadliest diseases worldwide). To our knowledge, the present study is the first to report the antimycobacterial activity of imidazole-fused heterocycles. OBJECTIVE: Construction of some bis-imidazole fused heterocycles with potential anti-tubercular and/or potent antitumor activities. METHODS: A series of bis-imidazole fused derivatives 6-8 and 13-16 was constructed using bisphenacyl bromide derivative 2 as a synthetic platform. Compound 2 was also used to access bisquinoxaline 20, bis-benzothiazine derivatives 23, and bis-thiazolopyrimidine derivatives 26. The new bis-imidazole derivatives were evaluated for their anticancer activity against the lung carcinoma cell line (A-549) using Cisplatin as a reference drug. The new compounds were also screened for their anti-tubercular activity against M. tuberculosis (ATCC 25177) using Isoniazid as a reference drug. RESULTS: Among the new bis-imidazole derivatives, three examples showed remarkable antitumor activities while five other compounds showed high antimycobacterial activity. CONCLUSION: A novel series of bis-imidazole fused heterocycles was developed. Multiple prototypes of this new series showed remarkable anti-tubercular and/or potent antitumor activities.


Subject(s)
Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacology , Antitubercular Agents/chemical synthesis , Antitubercular Agents/pharmacology , Imidazoles/chemical synthesis , Imidazoles/pharmacology , Molecular Docking Simulation , Antineoplastic Agents/chemistry , Antineoplastic Agents/metabolism , Antitubercular Agents/chemistry , Antitubercular Agents/metabolism , Chemistry Techniques, Synthetic , Imidazoles/chemistry , Imidazoles/metabolism , Mycobacterium tuberculosis/drug effects , Structure-Activity Relationship
6.
Chem Commun (Camb) ; 48(8): 1141-3, 2012 Jan 28.
Article in English | MEDLINE | ID: mdl-22167176

ABSTRACT

Successful incorporation of triptycene into benzimidazole-linked polymers leads to the highest CO(2) uptake (5.12 mmol g(-1), 273 K and 1 bar) by porous organic polymers and results in high CO(2)/N(2) (63) and CO(2)/CH(4) (8.4) selectivities.

8.
J Am Chem Soc ; 131(48): 17714-8, 2009 Dec 09.
Article in English | MEDLINE | ID: mdl-19899794

ABSTRACT

A unified approach to the pyrrolidine triacid natural products isodomoic acids G and H has been developed. Total syntheses of both natural products were completed, and determination of the correct stereostructure of isodomoic acid G was established by comparing 5'-(R) and 5'-(S) isomers to a sample of authentic material. A nickel-catalyzed cyclization constructs the pyrrolidine ring while simultaneously establishing either the E or Z stereochemistry of an exocyclic tetrasubstituted alkene. Stereoselective assembly of both the E- and Z-alkenes of the natural products is made possible by a predictable strategy that alters the timing of substituent introduction to control alkene stereochemistry.


Subject(s)
Alkenes/chemistry , Alkenes/chemical synthesis , Heptanoic Acids/chemical synthesis , Biological Products/chemical synthesis , Biological Products/chemistry , Cyclization , Heptanoic Acids/chemistry , Stereoisomerism , Substrate Specificity
9.
Inorg Chem ; 42(7): 2176-8, 2003 Apr 07.
Article in English | MEDLINE | ID: mdl-12665343

ABSTRACT

The interaction of the trinuclear mercury(II) complex [(o-C(6)F(4)Hg)(3)] (1) and pyrene leads to the formation of the 1:1 adduct 1.pyrene. The crystal structure of this adduct reveals the existence of supramolecular stacks in which molecules of 1 and molecules of pyrene alternate along the infinite chains. Steady-state and time-resolved photoluminescence measurements indicate the occurrence of a heavy atom effect which results in red, green, and blue (RGB) phosphorescent emissions for 1.pyrene, 1.naphthalene, and 1.biphenyl, respectively.

SELECTION OF CITATIONS
SEARCH DETAIL
...